Reata Pharmaceuticals Inc. (NASDAQ: RETA) has filed an S-1 form with the SEC for a secondary offering. The company did not disclose any pricing data, except that the offering is valued at roughly $86.25 million. The most recent closing price was $25.79 a share.
Over the past week, shares dropped about 18% to close out at $21.30. The consensus price target is $48.00. The 52-week range is $11.03 to $41.60.
When Restoration Hardware Holdings Inc. (NYSE: RH) reported its fiscal third-quarter results late Thursday, it said that it had $0.19 in earnings per share (EPS) and $549.3 million in revenue. The consensus estimates had called for $0.16 in EPS and revenue of $532.5 million. In the same period of last year, the retailer posted EPS of had $0.65 and $532.41 million in revenue.
Comparable brand revenue, which includes direct revenue, declined 6% in the third quarter when compared to 7% growth for the same period last year.
In terms of the outlook for the fiscal fourth quarter, the company expects to see EPS in the range of $0.60 to $0.70 and revenues between $562 million and $592 million. However, consensus estimates so far see a little more: $1.08 in EPS and $637.62 million in revenue.
Over the past week, Restoration Hardware shares retreated 9%. They were last trading at $31.92. The consensus price target is $41.31, and the 52-week range is $24.75 to $89.78.
Ohr Pharmaceutical Inc. (NASDAQ: OHRP) shares dropped on Thursday after the company announced the pricing of a secondary offering. The company intends to price 3.875 million shares at $2 apiece. There is also an interesting warrant option that comes with this offering. The company expects the total gross proceeds from this offering to be $7.75 million. Keep in mind the company has a market cap of roughly $62 million.
Over the week, shares were down 23.5%. The stock closed Friday at $1.95, with a consensus price target of $9.33 and a 52-week trading range of $1.80 to $6.56.
Duluth Holdings Inc. (NASDAQ: DLTH) fiscal third-quarter earnings report showed $0.01 in EPS and $67 million in revenue. The consensus estimates had called for a breakeven on earnings and revenue of $69 million. The same period of last year reportedly had $0.04 in EPS and $55.3 million in revenue.
In terms of the outlook for this fiscal year, the company expects to see net sales of between $360 million and $370 million and GAAP-EPS in the range of $0.52 to $0.60. The consensus estimates are $0.70 in EPS and $380.13 million in revenue.
Over the past week, the stock dropped by more than 13%. Shares were trading at $28.55 on Friday’s close, with a consensus price target of $36.00 and a 52-week range of $13.52 to $38.19.